Erysaa

Erysaa Contraindications

epoetin alfa

Manufacturer:

Duopharma (M)

Distributor:

DKSH
Full Prescribing Info
Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Hypersensitivity to mammalian cell- derived products.
Uncontrolled hypertension.
Patients who develop antibody-mediated Pure Red Cell Aplasia (PRCA) following treatment with any erythropoietin should not receive Epoetin alfa or any other erythropoietin.
All contraindications associated with autologous blood predonation programs should be respected in patients being supplemented with ESA.
Patients scheduled for elective surgery, who are not participating in an autologous blood pre-deposit programme and who have severe coronary, peripheral arterial, carotid or cerebral vascular disease, including Patients with recent myocardial infarction or cerebral vascular accident.
Surgery Patients who for any reason cannot receive adequate antithrombotic prophylaxis or treatment.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in